Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
Tuesday, December 17, 2024 at 8:00 am EST December 16, 2024 18:15…
Sign in to your account